[ Pobierz całość w formacie PDF ]
100 Questions & Answers
About Restless Legs
Syndrome
Sudhansu Chokroverty, MD, FRCP, FACP
Professor and Co-Chair of Neurology
Program Director of Clinical Neurophysiology & Sleep Medicine
New Jersey Neuroscience Institute at JFK Medical Center
Seton Hall University
Edison, NJ
World Headquarters
Jones & Bartlett Learning
40 Tall Pine Drive
Sudbury, MA 01776
978-443-5000
info@jblearning.com
www.jblearning.com
Jones & Bartlett Learning
Canada
6339 Ormindale Way
Mississauga, Ontario L5V 1J2
Canada
Jones & Bartlett Learning
International
Barb House, Barb Mews
London W6 7PA
United Kingdom
Jones & Bartlett Learning books and products are available through most bookstores and online
booksellers. To contact Jones & Bartlett Learning directly, call 800-832-0034, fax 978-443-8000, or
visit our website, www.jblearning.com.
Substantial discounts on bulk quantities of Jones & Bartlett Learning publications are available to
corporations, professional associations, and other qualified organizations. For details and specific
discount information, contact the special sales department at Jones & Bartlett Learning via the
above contact information or send an email to specialsales@jblearning.com.
Copyright © 2011 by Jones & Bartlett Learning, LLC
All rights reserved. No part of the material protected by this copyright may be reproduced or utilized
in any form, electronic or mechanical, including photocopying, recording, or by any information
storage and retrieval system, without written permission from the copyright owner.
The author, editor, and publisher have made every effort to provide accurate information. However,
they are not responsible for errors, omissions, or for any outcomes related to the use of the contents
of this book and take no responsibility for the use of the products and procedures described. Treat-
ments and side effects described in this book may not be applicable to all people; likewise, some peo-
ple may require a dose or experience a side effect that is not described herein. Drugs and medical
devices are discussed that may have limited availability controlled by the Food and Drug Adminis-
tration (FDA) for use only in a research study or clinical trial. Research, clinical practice, and gov-
ernment regulations often change the accepted standard in this field. When consideration is being
given to use of any drug in the clinical setting, the healthcare provider or reader is responsible for
determining FDA status of the drug, reading the package insert, and reviewing prescribing informa-
tion for the most up-to-date recommendations on dose, precautions, and contraindications, and
determining the appropriate usage for the product. This is especially important in the case of drugs
that are new or seldom used.
Production Credits
Executive Publisher: Christopher Davis
Editorial Assistant: Sara Cameron
Associate Production Editor: Leah Corrigan
Associate Marketing Manager: Katie Hennessy
Manufacturing and Inventory Control
Supervisor: Amy Bacus
Composition: Glyph International
Cover Design: Carolyn Downer
Cover Images: (top) © Dmitriy Shironosov/
ShutterStock, Inc., (bottom left)
© Les3photo8/Dreamstime.com,
(bottom right) © Photos.com
Printing and Binding: Malloy, Inc.
Cover Printing: Malloy, Inc.
Library of Congress Cataloging-in-Publication Data
Chokroverty, Sudhansu.
100 questions and answers about restless legs syndrome (RLS) / S. Chokroverty.
p. cm.—(100 questions and answers)
title: Hundred questions and answers about restless legs syndrome (RLS)
Includes index.
ISBN 978-0-7637-8094-4 (alk. paper)
1. Restless legs syndrome—Miscellanea. 2. Restless legs syndrome—Popular works. I. Title.
II. Title: Hundred questions and answers about restless legs syndrome (RLS).
RC548.5.C46 2011
616.8'498—dc22
2010025890
6048
Printed in the United States of America
14 13 12 11 10 10 9 8 7 6 5 4 3 2 1
Contents
Preface and Acknowledgment
v
Part 1: The Basics
Questions 1–5
provide important, basic information on restless legs syndrome (RLS):
•
•
•
Part 2: Risk, Prevention, and Epidemiology of
Restless Legs Syndrome
15
Questions 6–20
discuss risk factors associated with the development of RLS:
•
•
this condition permanently?
•
•
their symptoms adequately?
Part 3: Symptoms and Diagnosis of Restless Legs Syndrome
31
Questions 21–44
review the symptoms of this uncomfortable condition as well as
the diagnosis process:
•
•
•
systemic disease?
•
Part 4: Physical and Psychological Effects
of Restless Legs Syndrome
71
Questions 45–65
discuss the numerous ways RLS can affect both the physical and
psychological aspects of life:
•
high blood pressure, stroke, or heart disease. Is this true and how does RLS
cause these conditions?
100 QUESTIONS & ANSWERS ABOUT RESTLESS LEGS SYNDROME
•
gambling, smoking, or eating?
•
Part 5: Treatment of Restless Legs Syndrome
Questions 66–94
review the different treatment options available to those suffering
from RLS:
•
treat and when to treat?
•
•
I take sleeping medications in addition to RLS drugs?
Part 6: Coping and Management Techniques
Questions 95–100
explain coping techniques that can assist in managing RLS and
help you live a productive, happy life:
•
•
•
Appendix
157
Glossary
161
Index
165
iv
[ Pobierz całość w formacie PDF ]